Atlas Trials

Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction

Clinical trial NCT05168709 · COMPLETED

Trial details

NCT number
NCT05168709
Sponsor
Murdoch Childrens Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Vaccine ReactionImmunization; Infection
Start date
2022-01-20
Primary completion
2022-09-29
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.